My Good News

Chennai, India Founded: 2021 • Age: 5 yrs
Provides a mobile app for tracking womens fertility periods.

About My Good News

My Good News is a Healthcare company based in Chennai (India) founded in 2021. It provides a mobile app for tracking womens fertility periods. It operates on a B2C model. Its Indian entity Gensera Biotech Solutions Private Limited reported revenue of β‚Ή34.2 Lakh. Its focus areas include Health and Wellness, Women's Health, Fertility Tracking and Mobile Apps.

Company details

My Good News, founded in 2021 in Chennai, India, focuses on promoting health and well-being, womens health, fertility tracking, and mobile apps. Provides a mobile app for tracking womens fertility periods. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Key Metrics
  • Annual Revenue
    ₹34.2 Lakh

    FY 2023 · +509% YoY

  • Net Loss
    -₹4.8 Lakh

    FY 2023 · -14% margin

  • EBITDA
    -₹4.8 Lakh

    FY 2023 · -14% margin

Board of directors of Gensera Biotech Solutions Private Limited (My Good News)

Gensera Biotech Solutions Private Limited is the primary company behind My Good News. The board of Gensera Biotech Solutions Private Limited currently have 3 directors; the longest-serving is Shrinivas Rangachari, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Shrinivas Rangachari
DIN 07520424
Director31 Aug 20197 yrs 2 moGensera Biotech Solutions Private Limited
Velmurugan Balasubramanian
DIN 08136055
Director31 Aug 20197 yrs 2 moGensera Biotech Solutions Private Limited
Vasanthi Palanivel
DIN 07916907
Director20 Apr 20215 yrs 6 moGensera Biotech Solutions Private Limited

Financials of My Good News

Figures of Gensera Biotech Solutions Private Limited, the primary company behind My Good News, for FY 2023. Revenue was ₹34.2 Lakh (+509% year on year). Net loss was -₹4.8 Lakh (-14% margin). EBITDA was -₹4.8 Lakh (-14% margin).

  • ₹34.2 LakhRevenue · FY 2023 · +509% YoY
  • -₹4.8 LakhNet loss · -14% margin
  • -₹4.8 LakhEBITDA · -14% margin
  • ₹1 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Gensera Biotech Solutions Private Limited are on its company page.

Premium access

Detailed financial statements for My Good News

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about My Good News

My Good News was founded in 2021.

My Good News is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

The primary company behind My Good News, Gensera Biotech Solutions Private Limited, reported revenue of β‚Ή34.2 Lakh for FY 2023, up 509% year on year.

My Good News, founded in 2021 in Chennai, India, focuses on promoting health and well-being, womens health, fertility tracking, and mobile apps. Provides a mobile app for tracking womens fertility periods. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

My Good News operates through Gensera Biotech Solutions Private Limited.

The legal entities of My Good News currently have 3 directors, including Vasanthi Palanivel, Shrinivas Rangachari, Velmurugan Balasubramanian.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available